Ginkgo Bioworks Holdings, Inc.
DNA
$7.54
-$0.27-3.46%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 561.57M | 616.21M | 730.37M | 840.44M | 944.07M |
Total Receivables | 22.44M | 24.47M | 29.83M | 37.35M | 30.19M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 12.89M | 18.95M | 20.81M | 21.90M | 22.70M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 5.84M | 2.86M | 2.35M | 3.33M | 4.79M |
Total Current Assets | 602.74M | 662.48M | 783.36M | 903.02M | 1.00B |
|
|||||
Total Current Assets | 602.74M | 662.48M | 783.36M | 903.02M | 1.00B |
Net Property, Plant & Equipment | 598.16M | 616.95M | 628.59M | 416.78M | 394.99M |
Long-term Investments | -- | -- | -- | 47.91M | 49.24M |
Goodwill | -- | -- | -- | 47.91M | 49.24M |
Total Other Intangibles | 72.51M | 79.57M | 90.60M | 77.41M | 82.74M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 55.34M | 59.79M | 60.21M | 60.63M | 58.06M |
Total Assets | 1.38B | 1.48B | 1.63B | 1.58B | 1.67B |
|
|||||
Total Accounts Payable | 14.17M | 15.70M | 23.03M | 27.00M | 9.32M |
Total Accrued Expenses | 19.19M | 65.54M | 101.17M | 93.12M | 49.87M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 28.97M | -- | -- | -- | 17.47M |
Total Finance Division Other Current Liabilities | 44.94M | 33.19M | 41.96M | 48.93M | 87.20M |
Total Other Current Liabilities | 44.94M | 33.19M | 41.96M | 48.93M | 87.20M |
Total Current Liabilities | 107.27M | 114.43M | 166.15M | 169.04M | 163.86M |
|
|||||
Total Current Liabilities | 107.27M | 114.43M | 166.15M | 169.04M | 163.86M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 438.79M | 445.59M | 452.27M | 234.50M | 221.84M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 115.33M | 122.92M | 173.76M | 190.95M | 182.50M |
Total Liabilities | 661.39M | 682.94M | 792.18M | 594.49M | 568.19M |
|
|||||
Common Stock & APIC | 6.56B | 6.53B | 6.51B | 6.45B | 6.39B |
Retained Earnings | -5.84B | -5.73B | -5.67B | -5.46B | -5.29B |
Treasury Stock & Other | -1.81M | 263.00K | -1.72M | -1.55M | 1.48M |
Total Common Equity | 716.06M | 797.94M | 833.07M | 987.27M | 1.10B |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 716.06M | 797.94M | 833.07M | 987.27M | 1.10B |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 716.06M | 797.94M | 833.07M | 987.27M | 1.10B |
|